Grimes & Company’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.53M	Sell	14,981 -2,405	-14%	-$411K	0.07%	163
2025 Q4	$2.93M	Sell	17,386 -366	-2%	-$59.4K	0.07%	161
2025 Q3	$2.56M	Sell	17,752 -411	-2%	-$56.1K	0.06%	164
2025 Q2	$2.3M	Buy	+18,163	New	+$2.23M	0.06%	159
2025 Q1	–	Sell	-26,182	Closed	-$3.46M	–	387
2024 Q4	$3.46M	Buy	+26,182	New	+$3.68M	0.1%	116
2022 Q4	–	Sell	-2,080	Closed	-$243K	–	300
2022 Q3	$243K	Buy	2,080 +2	+0.1%	+$248	0.01%	238
2022 Q2	$244K	Hold	2,078	–	–	0.01%	239
2022 Q1	$271K	Sell	2,078 -682	-25%	-$88.8K	0.01%	248
2021 Q4	$421K	Buy	2,760 +187	+7%	+$29K	0.02%	215
2021 Q3	$416K	Buy	2,573 +78	+3%	+$13.1K	0.02%	210
2021 Q2	$408K	Buy	2,495 +35	+1%	+$5.39K	0.02%	211
2021 Q1	$370K	Sell	2,460 -83	-3%	-$13.2K	0.02%	213
2020 Q4	$385K	Buy	+2,543	New	+$363K	0.02%	203